Tag: Prescription Drugs

Risk for major adverse cardiac and cerebrovascular events lower compared with aspirin monotherapy for patients who undergo PCI and discontinue DAPT

Better event-free survival outcomes seen for durvalumab plus FLOT versus FLOT alone in phase 3 randomized trial

PrEP dispensing and initiation have increased but PrEP persistence has decreased

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer

Best corrected visual acuity improved 9.8 letters with lamivudine after four weeks, decreased 1.8 letters with placebo

Progression-free survival longer with vepdegestrant than fulvestrant in subgroup with ESR1 mutations, but not in the overall population

Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy

Severe exacerbation occurred in fewer patients receiving albuterol-budesonide versus those receiving albuterol only

Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours